Diabeto

Chicago, United States Founded: 2012 • Age: 14 yrs Acquired By Livongo
Diabetes monitoring and management app along with healthcare coaches

About Diabeto

Diabeto is a Healthcare company based in Chicago (United States) founded in 2012, and was acquired by Livongo in September 2017. Diabetes monitoring and management app along with healthcare coaches. Diabeto has raised $65 thousand across 2 funding rounds from investors including Livongo, SOSV and HAX. The company has 30 employees. The company was acqui-hired. Its focus areas include HealthTech, Disease Self Management, Diabetes and Monitoring. Its legal entity in India is Diabeto Healthtech Llp (AAH-6153). Its competitors include Glooko and Tidepool; 2 of its 2 listed competitors have raised funding.

Company details

Diabeto offers a mobile application for monitoring and managing diabetes. Features include logging food, mood, activity, and insulin; multiple device support; analysis and tracking; and data sharing. Also, offers subscription based diet coaching from expert dieticians. It has a Bluetooth hardware device which enables the transfer of glucose readings from a Glucometer into an application on a mobile device. The Diabeto Enterprise API (cloud-based) for iOS enables third-party application developers to build mobile applications that can, using the API, communicate over Bluetooth with Diabeto to fetch readings from various supported glucometers.

  • Headquarters Chicago, United States
  • Employees 30
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website diabe.to
  • Social LinkedIn X Facebook
  • Acquired by Livongo (Sep 2017)
  • Legal Name Diabeto Healthtech Llp
  • Date of Incorporation 17 Oct, 2016
  • Jurisdiction Mumbai, Maharashtra, India
Key Metrics
  • Annual Revenue
    $731.66 K (USD)
    79
    as on Mar 31, 2019
  • Net Profit
    $94.11 K (USD)
    115
    as on Mar 31, 2019
  • EBITDA
    $140.9 K (USD)
    133
    as on Mar 31, 2019
  • Total Equity Funding
    $65K (USD)

    in 2 rounds

  • Investors
    Livongo

    & 3 more

  • Employee Count
    30
  • Acquired by
    Livongo

    (Sep 2017)

Funding Insights of Diabeto

Diabeto has successfully raised a total of $65K across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $65,000
  • Total Rounds 2
  • First Round $65,000

    (Nov 2012)

  • Investors Count 3

All 2 funding rounds of Diabeto with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2016Seed––
Nov 2012$65,000Seed––
Valuation history

4 investors in total: 4 institutional.

Investors in Diabeto

Diabeto has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Livongo, SOSV and HAX.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital and accelerator services are provided across multiple sectors.
sosv.comCork, Ireland
Startups are accelerated via a 111-day program with seed funding.
hax.coSan Francisco, United States
Government-backed startup accelerator programs are operated in Chile.
startupchile.orgSantiago, Chile
Provider of smart devices for diabetes management for patients and doctors
2014livongo.comSan Francisco, United States
Premium access

Investor details for Diabeto

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Diabeto Healthtech Llp (Diabeto)

Diabeto Healthtech Llp is the primary company behind Diabeto. The boards of the 2 registered companies of Diabeto currently have 4 directors; the longest-serving is Shreekant Manohar Pawar, appointed in 2016. 5 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Shreekant Manohar Pawar
DIN 05000906
Designated Partner17 Oct 201610 yrsDiabeto Healthtech Llp
Hemanshu Sudhir Jain
DIN 06803731
Designated Partner17 Oct 201610 yrsDiabeto Healthtech Llp
Ajay Sharma
DIN 07941488
Director24 Apr 20188 yrs 5 moTeladoc Health India Private Limited
Sunita Jain Bolia
DIN 08785810
Director09 Jul 20206 yrs 3 moTeladoc Health India Private Limited

Timeline of Diabeto

4 dated milestones of Diabeto across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Diabeto is founded.
  2. Funding First funding round of $65K.
  3. Funding Latest funding round, Seed,.
  4. Exit Acquired by Livongo.

Competitors of Diabeto

Diabeto has 2 listed competitors in our database, 2 of them funded. They include Glooko and Tidepool.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
glooko.com2010Palo Alto, United States$201M121
Diabetes management is enabled via glucose meters and mobile apps.
tidepool.org2012San Francisco, United States$1.5M3
SaaS for Type 1 diabetes management is provided by Tidepool.
Premium access

Detailed competitors of Diabeto

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Diabeto

Websites that share an audience with Diabeto (diabe.to).

Similar websites

Websites whose visitors overlap most with Diabeto. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
justnaturalskincare.com
justnaturalskincare.com
100%
#5,789,784–

Top companies in Health Monitoring & Wearables

3 companies that operate in the same segment as Diabeto (Health Monitoring & Wearables) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Smart fitness equipment and streaming platforms are provided.
2011New York, New York, United StatesUSD 995.53 MUSD 2.45 B2,894
Wearable glucose monitoring patches are provided for real-time data tracking.
1999San Diego, California, United StatesUSD 52.5 MUSD 4.66 B10,300
Diabetes management is enabled via glucose meters and mobile apps.
2010Palo Alto, California, United StatesUSD 201 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Diabeto

Diabeto was founded in 2012.

Diabeto is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.

Diabeto is a funded company, having raised a total of $65K across 2 funding rounds to date. The company's 1st funding round was a Seed of $65K, raised on Nov 2012.

Diabeto has 30 employees.

Annual revenue of Diabeto is $731.66K as on Mar 31, 2019.

Diabeto offers a mobile application for monitoring and managing diabetes. Features include logging food, mood, activity, and insulin; multiple device support; analysis and tracking; and data sharing. Also, offers subscription based diet coaching from expert dieticians. It has a Bluetooth hardware device which enables the transfer of glucose readings from a Glucometer into an application on a mobile device. The Diabeto Enterprise API (cloud-based) for iOS enables third-party application developers to build mobile applications that can, using the API, communicate over Bluetooth with Diabeto to fetch readings from various supported glucometers.

Diabeto's top competitors include Glooko and Tidepool.

Diabeto has 4 investors. Key investors include Livongo, SOSV, HAX, and Start-Up Chile.

Diabeto is associated with 2 legal entities: Diabeto Healthtech Llp, Teladoc Health India Private Limited.

Yes. Diabeto was acquired by Livongo in September 2017.

The legal entities of Diabeto currently have 4 directors, including Shreekant Manohar Pawar, Hemanshu Sudhir Jain, Sunita Jain Bolia and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available